Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the…
Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…